Pituitary incidentalomas

Endocrinologist

Volumn 13, Issue 2, 2003, Pages 124-135

  Chanson, Philippe ^a,b   Young, Jacques ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GROWTH HORMONE; HYPOPHYSIS HORMONE; PROLACTIN;

ACROMEGALY; ADRENAL CORTEX ADENOMA; ADULT; CALCIFICATION; CASE REPORT; CORTICOTROPIN RELEASE; CRANIOPHARYNGIOMA; CUSHING DISEASE; DIAGNOSTIC IMAGING; FEMALE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; HYPOPITUITARISM; MALE; MICROADENOMA; NERVE COMPRESSION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; PROLACTIN RELEASE; PROLACTINOMA; REVIEW; SYMPTOMATOLOGY; TREATMENT INDICATION; TUMOR VOLUME;

EID: 0038625152     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000076215.95014.4c     Document Type: Review

References (48)

1. Molitch ME, Russell EJ. The pituitary "incidentaloma." Ann Intern Med 1990; 112: 925-31.
2. Teramoto A, Hirakawa K, Sanno N, et al.: Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 1994; 193: 161-4.
3. Reincke M, Allolio B, Saeger W, et al.: The 'incidentaloma' of the pituitary gland. Is neurosurgery required? Jama 1990; 263: 2772-6.
4. Donovan LE, Corenblum B. The natural history of the pituitary incidentaloma. Arch Intern Med 1995; 155: 181-3.
5. Molitch ME. Evaluation and treatment of the patient with a pituitary incidentaloma. J Clin Endocrinol Metab 1995; 80: 3-6.
6. King JT, Jr., Justice AC, Aron DC. Management of incidental pituitary microadenomas: a cost-effectiveness analysis. J Clin Endocrinol Metab 1997; 82: 3625-32.
7. Feldkamp J, Santen R, Harms E, et al.: Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas-results of a prospective study. Clin Endocrinol (Oxf) 1999; 51: 109-113.
8. Aron DC, Howlett TA. Pituitary incidentalomas. Endocrinol Metab Clin North Am 2000; 29: 205-21.
9. Bailey RH, Aron DC. The diagnostic dilemma of incidentalomas. Working through uncertainty. Endocrinol Metab Clin North Am 2000; 29: 91-105.
10. Howlett TA, Como J, Aron DC. Management of pituitary incidentalomas. A survey of British and American endocrinologists. Endocrinol Metab Clin North Am 2000; 29: 223-30.
11. Chanson P, Daujat F, Young J, et al.: Normal pituitary hypertrophy as a frequent cause of pituitary incidentaloma: a follow-up study. J Clin Endocrinol Metab 2001; 86: 3009-15.
12. Chidiac RM, Aron DC. Incidentalomas. A disease of modern technology. Endocrinol Metab Clin North Am 1997; 26: 233-53.
13. Hall WA, Luciano MG, Doppman JL, et al.: Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994; 120: 817-820.
14. Nammour GM, Ybarra J, Naheedy MH, et al.: Incidental pituitary macroadenoma: a population-based study. Am J Med Sci 1997; 314: 287-91.
15. Yue NC, Longstreth WT, Jr., Elster AD, et al.: Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. Radiology 1997; 202: 41-6.
16. Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am 1999; 28: 81-117, vi.
17. Baskin DS, Wilson CB. Surgical management of craniopharyngiomas. A review of 74 cases. J Neurosurg 1986; 65: 22-7.
18. Tsuchiya K, Makita K, Furui S, et al.: MRI appearances of calcified regions within intracranial tumours. Neuroradiology 1993; 35: 341-4.
19. Mukherjee JJ, Islam N, Kaltsas G, et al.: Clinical, radiological and pathological features of patients with Rathkes cleft cysts: tumors that may recur. J Clin Endocrinol Metab 1997; 82: 2357-62.
20. Shin JL, Asa SL, Woodhouse LJ, et al.: Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathkes cleft cyst, and arachnoid cyst. J Clin Endocrinol Metab 1999; 84: 3972-82.
21. Bunin GR, Surawicz TS, Witman PA, et al.: The descriptive epidemiology of craniopharyngioma. J Neurosurg 1998; 89: 547-51.
22. Miyai K, Ichihara K, Kondo K, et al.: Asymptomatic hyperprolactinaemia and prolactinoma in the general population-mass screening by paired assays of serum prolactin. Clin Endocrinol (Oxf) 1986; 25: 549-54.
23. Vanderpump MP, French JM, Appleton D, et al.: The prevalence of hyperprolactinaemia and association with markers of autoimmune thyroid disease in survivors of the Whickham Survey cohort. Clin Endocrinol (Oxf) 1998; 48: 39-44.
24. Annegers JF, Coulam CB, Abboud CF, et al.: Pituitary adenoma in Olmsted County, Minnesota, 1935-1977. A report of an increasing incidence of diagnosis in women of childbearing age. Mayo Clin Proc 1978; 53: 641-3.
25. Shy KK, McTiernan AM, Daling JR, et al.: Oral contraceptive use and the occurrence of pituitary prolactinoma. Jama 1983; 249: 2204-7.
26. Alexander L, Appleton D, Hall R, et al.: Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) 1980; 12: 71-9.
27. Bengtsson B-A, Eden S, Ernest I, et al.: Epidemiology and long-term survival in acromegaly. Acta Med Scand 1988; 223: 327-35.
28. Etxabe J, Vazquez JA. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) 1994; 40: 479-84.
29. Chanson P. Pituitary tumors: overview of therapeutic options. In: Becker KL, ed. Principles and Practice of Endocrinology & Metabolism, 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2000: 182-194.
30. Beck-Peccoz P, Brucker-Davis F, Persani L, et al.: Thyrotropinsecreting pituitary adenomas. Endocr Rev 1996; 17: 610-38.
31. Horvath E, Kovacs K, Scheithauer BW. Pituitary hyperplasia. Pituitary 1999; 1: 169-180.
32. Bergland RM, Ray BS, Torack RM. Anatomical variations in the pituitary gland and adjacent structures in 225 human autopsy cases. J Neurosurg 1968; 28: 93-9.
33. Bonneville JF, Cattin F, Dietemann JL. Hypothalamic-pituitary region: computed tomography imaging. Baillieres Clin Endocrinol Metab 1989; 3: 35-71.
34. Cox TD, Elster AD. Normal pituitary gland: changes in shape, size, and signal intensity during the 1st year of life at MR imaging. Radiology 1991; 179: 721-4.
35. Doraiswamy PM, Potts JM, Axelson DA, et al.: MR assessment of pituitary gland morphology in healthy volunteers: age- and genderrelated differences. AJNR Am J Neuroradiol 1992; 13: 1295-9.
36. Elster AD, Chen MY, Williams DWD, et al.: Pituitary gland: MR imaging of physiologic hypertrophy in adolescence [see comments]. Radiology 1990; 174: 681-5.
37. Lurie SN, Doraiswamy PM, Husain MM, et al.: In vivo assessment of pituitary gland volume with magnetic resonance imaging: the effect of age. J Clin Endocrinol Metab 1990; 71: 505-8.
38. Sakamoto Y, Takahashi M, Korogi Y, et al.: Normal and abnormal pituitary glands: gadopentetate dimeglumine- enhanced MR imaging. Radiology 1991; 178: 441-5.
39. Suzuki M, Takashima T, Kadoya M, et al.: Height of normal pituitary gland on MR imaging: age and sex differentiation. J Comput Assist Tomogr 1990; 14: 36-9.
40. Tsunoda A, Okuda O, Sato K. MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and in climacterium. AJNR Am J Neuroradiol 1997; 18: 551-4.
41. Naidich MJ, Russell EJ. Current approaches to imaging of the sellar region and pituitary. Endocrinol Metab Clin North Am 1999; 28: 45-79.
42. Gonzalez JG, Elizondo G, Saldivar D, et al.: Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 1988; 85: 217-20.
43. Elster AD, Sanders TG, Vines FS, et al.: Size and shape of the pituitary gland during pregnancy and post partum: measurement with MR imaging. Radiology 1991; 181: 531-5.
44. Orth DN. Corticotropin-releasing hormone in humans. Endocr Rev 1992; 13: 164-91.
45. Sano T, Asa SL, Kovacs K. Growth hormone-releasing hormoneproducing tumors: Clinical, biochemical, and morphological manifestations. Endocr Rev 1988; 9: 357-73.
46. Horvath E. Pituitary hyperplasia. Pathol Res Pract 1988; 183: 623-5.
47. Peillon F, Dupuy M, Li JY, et al.: Pituitary enlargement with suprasellar extension in functional hyperprolactinemia due to lactotroph hyperplasia: a pseudotumoral disease. J Clin Endocrinol Metab 1991; 73: 1008-15.
48. Perignon F, Brauner R, Argyropoulou M, et al.: Precocious puberty in girls: pituitary height as an index of hypothalamo-pituitary activation. J Clin Endocrinol Metab 1992; 75: 1170-2.